Micromedex Complete Drug Interactions (formerly Drug-Reax® System) is an evidence-based, comprehensive clinical decision support (CDS) tool designed to help healthcare professionals proactively identify and manage potential adverse drug events (ADEs) at the point of care . The solution is a core component of the Micromedex Clinical Knowledge Suite, which originated from Truven Health Analytics, acquired by IBM Watson Health, and is now part of Merative .
Key Features and Capabilities:
- Comprehensive Interaction Screening: The tool checks for a total of nine interaction types, including drug-drug (including herbal), drug-food, drug-ethanol, drug-laboratory, drug-tobacco, drug-pregnancy, drug-lactation, and ingredient duplication .
- Risk Evaluation: It provides a clear, easy-to-understand five-level warning system for interaction severity and a four-level documentation rating system to assess the quality and nature of the interaction evidence .
- Workflow Integration: Micromedex solutions are designed for seamless integration into Electronic Health Record (EHR) systems nationwide, ensuring quick access to critical information within the workflow of physicians, pharmacists, and nurses .
- Content Authority: The content is fully synopsized, referenced, and developed by an in-house editorial team, with the editorial process accredited by the National Institute for Health and Care Excellence (NICE) .
- Accessibility: The solution is accessible via desktop, mobile applications, and EHR integration, supporting a streamlined workflow .
Target Users and Use Cases:
- Target Users: Pharmacists, Physicians, Nurses, Clinical Staff, Health IT Leaders, and Academic Centers .
- Use Cases: Reducing medication errors and ADEs, supporting medication therapy management, providing clinical decision support at the point of care, and supporting regulatory and quality initiatives .
